Sales in Q4 were slightly better than expected and supply chain/cost headwinds have been managed in line with previously revised assumptions. Consequently, adj EBITDA is in line with market expectations. With price rises starting to work their way through, a strong order book (up significantly LFL) and commercial progress on contracts, there is a growing level of confidence in the year ahead. With the shares having pulled back, we move to Buy.